ATE286911T1 - Transkriptionsfaktor und dessen dna - Google Patents
Transkriptionsfaktor und dessen dnaInfo
- Publication number
- ATE286911T1 ATE286911T1 AT00977879T AT00977879T ATE286911T1 AT E286911 T1 ATE286911 T1 AT E286911T1 AT 00977879 T AT00977879 T AT 00977879T AT 00977879 T AT00977879 T AT 00977879T AT E286911 T1 ATE286911 T1 AT E286911T1
- Authority
- AT
- Austria
- Prior art keywords
- present
- polypeptide
- dna
- activity
- preventives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP33647599 | 1999-11-26 | ||
PCT/JP2000/008257 WO2001038392A1 (fr) | 1999-11-26 | 2000-11-24 | Nouveau facteur de transcription et son adn |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE286911T1 true ATE286911T1 (de) | 2005-01-15 |
Family
ID=18299528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00977879T ATE286911T1 (de) | 1999-11-26 | 2000-11-24 | Transkriptionsfaktor und dessen dna |
Country Status (8)
Country | Link |
---|---|
US (1) | US7241860B1 (de) |
EP (1) | EP1233023B1 (de) |
JP (1) | JP2001211890A (de) |
AT (1) | ATE286911T1 (de) |
AU (1) | AU1549701A (de) |
CA (1) | CA2392351A1 (de) |
DE (1) | DE60017453T2 (de) |
WO (1) | WO2001038392A1 (de) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05178896A (ja) * | 1990-08-23 | 1993-07-20 | Mitsubishi Kasei Corp | 新規なタンパク質、それをコードする遺伝子及びその産生方法 |
JP3585180B2 (ja) | 1993-05-11 | 2004-11-04 | 三菱化学株式会社 | 新規なヒトタンパク質およびそれをコードする遺伝子 |
US5851775A (en) * | 1997-03-20 | 1998-12-22 | Johns Hopkins University | β-catenin, Tcf-4, and APC interact to prevent cancer |
-
2000
- 2000-11-24 WO PCT/JP2000/008257 patent/WO2001038392A1/ja active IP Right Grant
- 2000-11-24 DE DE60017453T patent/DE60017453T2/de not_active Expired - Lifetime
- 2000-11-24 AT AT00977879T patent/ATE286911T1/de not_active IP Right Cessation
- 2000-11-24 EP EP00977879A patent/EP1233023B1/de not_active Expired - Lifetime
- 2000-11-24 JP JP2000357232A patent/JP2001211890A/ja active Pending
- 2000-11-24 CA CA002392351A patent/CA2392351A1/en not_active Abandoned
- 2000-11-24 US US10/130,872 patent/US7241860B1/en not_active Expired - Fee Related
- 2000-11-24 AU AU15497/01A patent/AU1549701A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE60017453T2 (de) | 2005-12-22 |
CA2392351A1 (en) | 2001-05-31 |
EP1233023B1 (de) | 2005-01-12 |
AU1549701A (en) | 2001-06-04 |
JP2001211890A (ja) | 2001-08-07 |
DE60017453D1 (de) | 2005-02-17 |
EP1233023A1 (de) | 2002-08-21 |
US7241860B1 (en) | 2007-07-10 |
EP1233023A4 (de) | 2003-01-02 |
WO2001038392A1 (fr) | 2001-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69841850D1 (de) | Differenzierung in osteoblasten der fettgewebe-stromalen zellen und ihre verwendungen | |
BR9810651A (pt) | Certos derivados de diarilimidazol; uma nova classe de ligantes npy especìficos | |
IL136738A0 (en) | Inhibition of p38 kinase activity using substituted heterocyclic ureas | |
AP0202538A0 (en) | Inhibitors of interleukin -1b converting enzyme. | |
HK1155944A1 (en) | W-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors | |
HU9500673D0 (en) | Novel rapamycin binding proteins and their diagnostic and therapeutic use | |
ATE253385T1 (de) | Hochmineralisierte osteogene schwammzusammensetzungen und ihre verwendung | |
IL143266A0 (en) | Transforming growth factor-beta binding proteins and pharmaceutical compositions for increasing bone mineral content utilizing the same | |
ES2151467T1 (es) | Inhibicion de la actividad de la quinasa p38 por aril-ureas. | |
HK1031832A1 (en) | Inhibition of p38 kinase activity using aryl and heteroaryl substituted heterocyclic ureas | |
BR0009505A (pt) | Compostos e processos para terapia e diagnóstico de câncer de pulmão | |
DE69837809D1 (de) | Apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dislipidemischer erkrankungen | |
ATE266675T1 (de) | Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese | |
JO2373B1 (en) | W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors | |
ATE252830T1 (de) | Neue psoralene zur inaktivierung von pathogenen | |
ZA9810735B (en) | Novel benzenesulfonamide inhibitors of pde-iv and their therapeutic use | |
WO1999037604A3 (en) | Dialkyl ureas as calcitonin mimetics | |
WO1999053040A3 (de) | Menschliche nukleinsäuresequenzen aus ovartumorgewebe | |
BR9711795A (pt) | Peptìdeos tendo propriedades antiproliferativas | |
Hannallah et al. | Gene therapy in orthopaedic surgery | |
WO2001042243A3 (en) | Protein kinase inhibitors | |
ATE286911T1 (de) | Transkriptionsfaktor und dessen dna | |
ATE266396T1 (de) | Zubereitung und verwendung von rar antagonisten zur forderung der chondrogenese | |
ATE533781T1 (de) | Heparin-bindungsstelle enthaltendes knochenmorphogenetisches protein 6 und osteogene vorrichtungen und pharmazeutische produkte, die diese enthalten | |
AU2001235696A1 (en) | Compositions useful for regulating parkin gene activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |